Corcept Therapeutics Incorporated (CORT)

NASDAQ: CORT · IEX Real-Time Price · USD

22.21

-0.27 (-1.20%)

At close: Apr 25, 2024, 4:00 PM

21.90

-0.31 (-1.40%)

After-hours: Apr 25, 2024, 5:48 PM EDT

Corcept Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2001
Revenue	482.38	401.86	365.98	353.87	306.49	251.25	159.2	81.32	50.29	26.55	Upgrade
Revenue Growth (YoY)	20.04%	9.80%	3.42%	15.46%	21.99%	57.82%	95.77%	61.72%	89.39%	156.36%	Upgrade
Cost of Revenue	6.48	5.39	5.28	5.58	5.5	5.22	3.55	2.06	1.36	0.88	Upgrade
Gross Profit	475.89	396.47	360.7	348.29	300.98	246.03	155.65	79.26	48.93	25.67	Upgrade
Selling, General & Admin	184.26	152.85	122.36	105.33	100.36	81.29	62.42	45.24	36.95	34.92	Upgrade
Research & Development	184.35	130.99	113.86	114.76	89.02	75.25	40.38	23.84	15.42	18.37	Upgrade
Operating Expenses	368.61	283.84	236.22	220.09	189.38	156.54	102.79	69.08	52.37	53.29	Upgrade
Operating Income	107.28	112.63	124.48	128.2	111.61	89.5	52.86	10.18	-3.44	-27.62	Upgrade
Interest Expense / Income	-17.28	-3.56	-0.53	-3.4	-5.07	-2.66	0.05	2.04	2.97	3.76	Upgrade
Other Expense / Income	0.64	0.13	-	-	-	-	-	-	-	-	Upgrade
Pretax Income	123.91	116.06	125.01	131.6	116.68	92.15	52.81	8.14	-6.41	-31.38	Upgrade
Income Tax	18.42	14.77	12.49	25.59	22.5	16.74	-76.32	0	0	0	Upgrade
Net Income	105.5	101.29	112.51	106.01	94.18	75.41	129.12	8.14	-6.41	-31.38	Upgrade
Net Income Growth	4.15%	-9.98%	6.13%	12.56%	24.89%	-41.60%	1486.27%	-	-	-	Upgrade
Shares Outstanding (Basic)	104	107	116	115	114	115	114	111	107	101	Upgrade
Shares Outstanding (Diluted)	112	116	126	124	123	127	125	116	107	101	Upgrade
Shares Change	-3.64%	-7.94%	1.42%	1.33%	-3.25%	1.75%	7.21%	8.66%	5.85%	1.16%	Upgrade
EPS (Basic)	1.02	0.95	0.97	0.92	0.82	0.65	1.14	0.07	-0.06	-0.31	Upgrade
EPS (Diluted)	0.94	0.87	0.89	0.85	0.77	0.60	1.04	0.07	-0.06	-0.31	Upgrade
EPS Growth	8.05%	-2.25%	4.71%	10.39%	28.33%	-42.31%	1385.71%	-	-	-	Upgrade
Free Cash Flow	126.9	119.91	167.42	150.73	135.03	115.37	60.52	18.2	3.11	-27.55	Upgrade
Free Cash Flow Per Share	1.23	1.12	1.45	1.31	1.18	1.00	0.53	0.17	0.03	-0.27	Upgrade
Gross Margin	98.66%	98.66%	98.56%	98.42%	98.20%	97.92%	97.77%	97.47%	97.29%	96.68%	Upgrade
Operating Margin	22.24%	28.03%	34.01%	36.23%	36.41%	35.62%	33.20%	12.52%	-6.85%	-104.02%	Upgrade
Profit Margin	21.87%	25.20%	30.74%	29.96%	30.73%	30.01%	81.11%	10.01%	-12.74%	-118.20%	Upgrade
Free Cash Flow Margin	26.31%	29.84%	45.75%	42.59%	44.06%	45.92%	38.01%	22.38%	6.19%	-103.76%	Upgrade
Effective Tax Rate	14.86%	12.73%	9.99%	19.45%	19.28%	18.17%	-144.52%	-	-	-	Upgrade
EBITDA	109	115.95	127.95	130.44	113.78	89.73	52.96	10.27	-3.29	-27.48	Upgrade
EBITDA Margin	22.60%	28.85%	34.96%	36.86%	37.12%	35.71%	33.27%	12.62%	-6.54%	-103.49%	Upgrade
Depreciation & Amortization	2.36	3.45	3.48	2.24	2.17	0.24	0.11	0.09	0.16	0.14	Upgrade
EBIT	106.64	112.5	124.48	128.2	111.61	89.5	52.86	10.18	-3.44	-27.62	Upgrade
EBIT Margin	22.11%	28.00%	34.01%	36.23%	36.41%	35.62%	33.20%	12.52%	-6.85%	-104.02%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).